Zoetis fires EVP Glenn David for undisclosed relationship; interim head named

Zoetis Inc.

Glenn David, EVP and Group President of U.S. Operations and Global Diagnostics, terminated Feb 5 for violating company policy (consensual personal relationship, failure to disclose).
David forfeits severance benefits and future equity vesting as a result of termination for cause.
William ('Chip') Dorsey, VP Finance, named interim head of U.S. Operations and Global Diagnostics; permanent search underway.
Company states conduct did not impact consolidated financial statements or internal controls over financial reporting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Glenn David

Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices

ZTS · Zoetis Inc.

Effective: 2023-02-05
Successor: William Dorsey
Filed: February 7, 2023, 6:59 PM ET

On February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc. (the “Company”), for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company.

Appointed (interim)

William Dorsey

interim head of U.S. Operations and Global Diagnostics

ZTS · Zoetis Inc.

Filed: February 7, 2023, 6:59 PM ET

William (“Chip”) Dorsey, Vice President, Finance will serve as interim head of U.S. Operations and Global Diagnostics while the Company conducts a search for Mr. David’s permanent replacement.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Glenn David was terminated as Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc..

Action: terminated
Role: Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices

Exact text from the filing

On February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc. (the “Company”), for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

William Dorsey was appointed as interim head of U.S. Operations and Global Diagnostics at Zoetis Inc..

Action: will serve as interim head
Role: interim head of U.S. Operations and Global Diagnostics

Exact text from the filing

William (“Chip”) Dorsey, Vice President, Finance will serve as interim head of U.S. Operations and Global Diagnostics while the Company conducts a search for Mr. David’s permanent replacement.

View on SEC.gov

Zoetis Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-011475

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.